Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;36(5):e23020.
doi: 10.1002/jbt.23020. Epub 2022 Mar 7.

Long noncoding RNA LBX2-AS1 promotes colorectal cancer progression via binding with PTBP1 and stabilizing KAT2A expression

Affiliations

Long noncoding RNA LBX2-AS1 promotes colorectal cancer progression via binding with PTBP1 and stabilizing KAT2A expression

Andong Zhao et al. J Biochem Mol Toxicol. 2022 May.

Abstract

The long noncoding RNAs (lncRNAs) have been investigated in colorectal cancer (CRC). The aim of this study is to identify the biological functions of LBX2-AS1 in CRC. Quantitative real-time polymerase chain reaction was used to examine the expression of LBX2-AS1 in CRC cells. Cell counting kit-8 and colony formation assays were performed to examine cell proliferation. Wound healing and transwell invasion assays were performed to examine the cell migration and invasion. The interaction between PTBP1 and LBX2-AS1 or KAT2A was confirmed by RNA immunoprecipitation. The KAT2A messenger RNA (mRNA) stability was probed using the transcriptional inhibitor Actinomycin D. LBX2-AS1 was significantly increased in CRC tissues and cells. Knockdown of LBX2-AS1 inhibited CRC cell proliferation, migration, and invasion. The notch signaling pathway was activated by LBX2-AS1. LBX2-AS1 enhanced the mRNA stability of the histone acetyltransferase KAT2A by interacting with RNA-binding protein PTBP1. LBX2-AS1 acted as an oncogene in CRC.

Keywords: KAT2A; PTBP1; colorectal cancer; long noncoding RNA LBX2-AS1.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, A. Jemal, CA Cancer J. Clin. 2018, 68(6), 394.
    1. Z. Štor, R. Blagus, A. Tropea, A. Biondi, Updates Surg. 2019, 71(4), 687.
    1. K. Van der Jeught, H. C. Xu, Y. J. Li, X. B. Lu, G. Ji, World J. Gastroenterol. 2018, 24(34), 3834.
    1. P. Han, J. W. Li, B. M. Zhang, J. C. Lv, Y. M. Li, X. Y. Gu, Z. W. Yu, Y. H. Jia, X. F. Bai, L. Li, Y. L. Liu, B. B. Cui, Mol. Cancer 2017, 16(1), 017.
    1. Q. Li, H. Xie, Z. Jin, J. Huang, S. Wang, Z. Zhang, Technol. Cancer Res. Treat. 2021, 20, 1533033821997829.

MeSH terms

LinkOut - more resources